PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Tchaikapharma High Quality Medicines Inc., Science Department, 1 G.M. Dimitrov Blvd, 1172, Sofia, Bulgaria. Electronic address: k.uzunova.hq@tchaikapharma.com.\', \'Tchaikapharma High Quality Medicines Inc., Science Department, 1 G.M. Dimitrov Blvd, 1172, Sofia, Bulgaria. Electronic address: e.filipova.hq@tchaikapharma.com.\', \'Tchaikapharma High Quality Medicines Inc., Science Department, 1 G.M. Dimitrov Blvd, 1172, Sofia, Bulgaria. Electronic address: v.pavlova.hq@tchaikapharma.com.\', \'Medical University, Dean of Faculty of Pharmacy, 1 Sv. Kliment Ohriski Str., 5800, Pleven, Bulgaria. Electronic address: t.vekov.mu.pleven@abv.bg.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0753-3322(20)30861-110.1016/j.biopha.2020.110668
?:doi
?:hasPublicationType
?:journal
  • Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
is ?:pmid of
?:pmid
?:pmid
  • 32861965
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all